Please assess the completion status of the following clinical trial:

Trial Title: Odiparcil For The Prevention Of Venous Thromboembolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women must be unable to have children.~* Will have a total knee replacement.~Exclusion Criteria:~* Allergic to any X-ray dye.~* Allergies or reactions to warfarin or coumadin.~* Previous VTE (venous thromboembolism) or deep vein thrombosis (DVT).~* On anticoagulation therapy.~* Renal impairment.~* Participated in any clinical trial in the past 30 days.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).